Genmab reported DKK66M in Ordinary Share Capital for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Amarin AMRN:US $ 294.66M 0.3M
Amgen AMGN:US $ 31343M 96M
Artemis Alpha ATS:LN 37.3M 0
AstraZeneca AZN:LN 387M 0M
Bayer BAYN:GR € 2515M 0M
Biomarin Pharmaceutical BMRN:US $ 0.19M 0M
Bluebird Bio BLUE:US $ 0.74M 0.02M
Exelixis EXEL:US $ 0.32M 0M
Galapagos GLPG:NA € 293.03M 0.43M
Genmab GEN:DC DK 66M 0M
GlaxoSmithKline GSK:LN 134700M 0M
GN Store Nord GN:DC DK 549M 4M
Hikma Pharmaceutical HIK:LN 3.37B 263.15M
Insmed INSM:US $ 1.2M 6K
Lonza Group LONN:SW 74M 0
Merck MRK:GR € 565M 0M
Novartis NOVN:VX SF 890M 11M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
William Demant Holding WDH:DC 46M 2M